Marksans Pharma sets Aug 20, 2026 as record date for ₹0.90 dividend

Marksans Pharma Limited's Board of Directors has fixed August 20, 2026, as the record date for determining shareholder eligibility for the final dividend for the financial year ended March 31, 2026. The recommended dividend is ₹0.90 per equity share. The 34th Annual General Meeting (AGM) will be held on August 27, 2026, via Video Conferencing. The final dividend, if approved at the AGM, will be paid on or after September 10, 2026, subject to tax deductions. The Board meeting where these decisions were made took place on July 3, 2026.